BIO-Europe Spring EBD Group BIO Image Map
Email this page Share this on LinkedIn Share this on Twitter

BIO-Europe Spring® 2015 Press Releases

December 16, 2014Paris, France will host BIO-Europe Spring® 2015 international life science partnering conference The ninth annual BIO-Europe Spring® conference will be held March 9–11, 2015 in Paris, France at the Paris expo Porte de Versailles conference center. This is the first time Paris will host a life science industry event of this scale, and it is expected to draw a large number of established biotech and early stage companies desiring to form business partnerships with invest...  more ►

November 20, 2014Spotlight on Paris Your browser does not support the video tag. Business Facts The Paris region is Europe's No. 1 business region with 842,000 businesses, from high tech sectors to traditional industrial activities. Paris is an innovation hotspot and has eight competitive clusters enhancing innovation, and the most generous research tax credits in Europe. There were 4,800 patents filed in the Paris re...  more ►

partnering360® Blog

May 18, 2015 Where Are They Now? The Life Sciences Report Small-Cap Watchlist Edition Guest post by Jim Patrick, Publisher, The Life Sciences Report It’s been four months since Streetwise Reports’ The Life Sciences Report‘s 2015 Small-Cap Biotech Watchlist was announced at the Biotech Showcase™ in San Francisco. Although our portfolio tracker follows the basket of... more ►

May 13, 2015 Bar raised for CAR-T cell therapy deal and IPO values Guest post by Raveena Bhambra, Senior Analyst at Current Partnering If you’ve not heard of CAR-T cell therapy and you’re based in the biotech industry, where have you been? Over the past year the technology has become one of the most talked about and anticipated technologies as promising... more ►

May 11, 2015 CRO report identifies trends and opportunities in the life science sector Guest post by Natalie Morrison, Senior Reporter at BioPharm Insight BioPharm Insight’s (BPI) 1Q15 CRO report, compiled by analyst Peter Murphy, delves into trends and opportunities in the life sciences services sector. The report notes oncology was the most trialed indication, totaling 20% of all... more ►

May 5, 2015 Help us reach our 30,000 members milestone and you could be a winner! partnering360®, your life science dealmaker network, is about to celebrate a milestone. We are nearing our 30,000th member, and as part of the celebration, we want to offer you a chance to win a FREE ticket to an EBD Group event. Simply encourage your colleagues and associates to join you as member... more ►

May 1, 2015 San Diego-based company defines what it means to be a “disruptor” You hear a lot these days about “disruptive technology” and “transformative science.” It’s a label many companies strive to achieve, but what does it look like in practice? San Diego based genome sequencing company Illumina is a good example of a “disruptive” biotech company. They... more ►

partnering360:Insight Latest headlines from partnering360:Insight

May 19, 2015 Aisling Capital: Strategies to survive the boom The biotech industry survived the financial valley of death of the past decade and emerged into a figurative land of milk and honey. Rejoice, but remain vigilant. These boom times are nearly as dangerous as the cash-strapped recent past. more ►

May 19, 2015 Lysosomal Therapeutics: Brilliant science, brilliant networks A cure for Parkinson’s disease may be possible if the research at Lysosomal Therapeutics, Inc. (LIT) advances as expected. Unlike therapies that treat the symptoms of this disease, LTI is developing a novel platform that addresses the root cause of the disease by working at the intersection of lysosomal storage disorders and neurodegenerative diseases. more ►

March 11, 2015 Sanofi , Medicen and other Paris Region clusters are leading the collaborative effort to bring ICT for Health innovation to the patient “We are working here in the Paris region to combine all the clusters that are linked to ICT for Health,” said Meunier. In particular, the three different clusters with three different technological areas of expertise involved are Medicen, Cap Digital, a software company, and Systematique Paris region, focused on ICT for Health. more ►

March 11, 2015 Targeting cancer stem cells may be key to a cure Something has been left behind in the billion-dollar "frothy" excitement over immuno-oncology therapies: recurrence of cancer and the inability to treat metastatic cancer. more ►

March 11, 2015 Academics pitch biotechs on early stage collaboration In the middle of a day filled with dealmaking and valuation of biotech assets, participants of BIO-Europe Spring® were treated to a refreshing hour of pure academia, including a half-hour lecture on the history of oncology. more ►

Arrow Up

See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2015 EBD GmbH
Privacy Policy
Terms of Use
BIO-Europe Spring EBD Group BIO Image Map